← Open Payments lookup

ALAYNA MIHILL: Open Payments

NPI 1194596411 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$828 in 46 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $469 · 2025 $828

Food & beverage: $828
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.14$159
Ipsen Biopharmaceuticals, Inc5$127
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$81
Ardelyx, Inc.4$77
Regeneron Healthcare Solutions, Inc.3$70
GENZYME CORPORATION3$65
ABBVIE INC.3$58
Phathom Pharmaceuticals, Inc.3$53
Janssen Biotech, Inc.1$26
Gilead Sciences, Inc.1$23

Products named: ENTYVIO, DUPIXENT, IQIRVO, IBSRELA, XIFAXAN, VOQUEZNA, RINVOQ, TREMFYA.

Industry payments across VA — which companies pay providers there.